Cargando…

Medical treatment of Cushing’s disease with concurrent diabetes mellitus

Cushing’s disease (CD) is a severe endocrine disorder characterized by chronic hypercortisolaemia secondary to an overproduction of adrenocorticotropic hormone (ACTH) by a pituitary adenoma. Cortisol excess impairs normal glucose homeostasis through many pathophysiological mechanisms. The varying de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mehlich, Anna, Bolanowski, Marek, Mehlich, Dawid, Witek, Przemysław
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150952/ https://www.ncbi.nlm.nih.gov/pubmed/37139336 http://dx.doi.org/10.3389/fendo.2023.1174119

Ejemplares similares

Levoketoconazole in the Treatment of Patients With Cushing’s Syndrome and Diabetes Mellitus: Results From the SONICS Phase 3 Study
por: Pivonello, Rosario, et al.
Publicado: (2021)

Diabetes Mellitus Secondary to Cushing’s Disease
por: Barbot, Mattia, et al.
Publicado: (2018)

Decreased Trabecular Bone Score in Patients With Active Endogenous Cushing’s Syndrome
por: Stachowska, Barbara, et al.
Publicado: (2021)

Individualized medical treatment options in Cushing disease
por: Gilis-Januszewska, Aleksandra, et al.
Publicado: (2022)

The patient’s sex determines the hemodynamic profile in patients with Cushing disease
por: Jurek, Agnieszka, et al.
Publicado: (2023)

Cushing’s Disease: Assessment of Early Cardiovascular Hemodynamic Dysfunction With Impedance Cardiography
por: Jurek, Agnieszka, et al.
Publicado: (2021)

The Effect of 6 Months’ Treatment With Pasireotide LAR on Glucose Metabolism in Patients With Resistant Acromegaly in Real-World Clinical Settings
por: Witek, Przemysław, et al.
Publicado: (2021)

Cushing’s Disease: Subclinical Left Ventricular Systolic and Diastolic Dysfunction Revealed by Speckle Tracking Echocardiography and Tissue Doppler Imaging
por: Uziębło-Życzkowska, Beata, et al.
Publicado: (2017)

Medical Treatment of Cushing's Disease: An Overview of the Current and Recent Clinical Trials
por: Pivonello, Rosario, et al.
Publicado: (2020)

The expression of glucocorticoid and mineralocorticoid receptors in pituitary tumors causing Cushing’s disease and silent corticotroph tumors
por: Kober, Paulina, et al.
Publicado: (2023)

Effectiveness of Medical Treatment of Cushing’s Disease: A Systematic Review and Meta-Analysis
por: Simões Corrêa Galendi, Julia, et al.
Publicado: (2021)

PMON315 Hyperglycemia Dilemma: Concomitant Type 1 Diabetes Mellitus and Cushing's disease
por: Ingley, Megan, et al.
Publicado: (2022)

Practical therapeutic approach in the management of diabetes mellitus secondary to Cushing’s syndrome, acromegaly and neuroendocrine tumours
por: Guarnotta, Valentina, et al.
Publicado: (2023)

Long-term efficacy and safety of osilodrostat in patients with Cushing’s disease: results from the LINC 4 study extension
por: Gadelha, Mônica, et al.
Publicado: (2023)

Cyclic Cushing’s Syndrome – A Diagnostic Challenge
por: Świątkowska-Stodulska, Renata, et al.
Publicado: (2021)

MLK4 regulates DNA damage response and promotes triple-negative breast cancer chemoresistance
por: Mehlich, Dawid, et al.
Publicado: (2021)

Distinct serum steroid profiles between adrenal Cushing syndrome and Cushing disease
por: Gao, Chang, et al.
Publicado: (2023)

Impact of Quenching Failure of Cy Dyes in Differential Gel Electrophoresis
por: Wang, Weiqun, et al.
Publicado: (2011)

Cushing’s syndrome is associated with altered adipokine profile
por: Dadej, Daniela, et al.
Publicado: (2022)

Experimental Investigation of the Solid Conveying Behavior of Smooth and Grooved Single-Screw Extruders at High Screw Speeds
por: Johann, Kai S., et al.
Publicado: (2022)

Pituitary-Directed Therapies for Cushing’s Disease
por: Langlois, Fabienne, et al.
Publicado: (2018)

Quality of Life in Patients With Cushing's Disease
por: Santos, Alicia, et al.
Publicado: (2019)

Cushing’s Disease Management: Glimpse Into 2051
por: Dalan, Rinkoo, et al.
Publicado: (2022)

Evaluation of ketoconazole as a treatment for Cushing’s disease in a retrospective cohort
por: Viecceli, Camila, et al.
Publicado: (2022)

The Pathophysiology and Treatment of Hypertension in Patients With Cushing's Syndrome
por: Barbot, Mattia, et al.
Publicado: (2019)

New Insights in Cushing Disease Treatment With Focus on a Derivative of Vitamin A
por: Fuertes, Mariana, et al.
Publicado: (2018)

Cyclic Cushing's Disease in the Prepubertal Period—A Case Report and Review of Literature
por: Wȩdrychowicz, Anna, et al.
Publicado: (2019)

Increased expression of the microRNA 106b~25 cluster and its host gene MCM7 in corticotroph pituitary adenomas is associated with tumor invasion and Crooke’s cell morphology
por: Garbicz, Filip, et al.
Publicado: (2017)

Hypercortisolemia Recurrence in Cushing's Disease; a Diagnostic Challenge
por: Hinojosa-Amaya, José Miguel, et al.
Publicado: (2019)

Significance of Crooke's Hyaline Change in Nontumorous Corticotrophs of Patients With Cushing Disease
por: Akirov, Amit, et al.
Publicado: (2021)

Slow Transition Path Times Reveal a Complex Folding Barrier in a Designed Protein
por: Mehlich, Alexander, et al.
Publicado: (2020)

Neuropsychiatric disorders in Cushing's syndrome
por: Pivonello, Rosario, et al.
Publicado: (2015)

A New Clinical Model to Estimate the Pre-Test Probability of Cushing’s Syndrome: The Cushing Score
por: Parasiliti-Caprino, Mirko, et al.
Publicado: (2021)

Toward a Diagnostic Score in Cushing's Syndrome
por: Braun, Leah T., et al.
Publicado: (2019)

Circulating microRNA Expression in Cushing’s Syndrome
por: Vetrivel, Sharmilee, et al.
Publicado: (2021)

Aggressive Cushing’s Disease: Molecular Pathology and Its Therapeutic Approach
por: Yamamoto, Masaaki, et al.
Publicado: (2021)

Editorial: Current Clinical and Pre-Clinical Progress in Cushing’s Disease
por: Stalla, Günter Karl, et al.
Publicado: (2020)

Functional brain alterations in Cushing’s syndrome
por: Papakokkinou, Eleni, et al.
Publicado: (2023)

Patients with Active Acromegaly are at High Risk of 25(OH)D Deficiency
por: Halupczok-Żyła, Jowita, et al.
Publicado: (2015)

Medical Therapy with Pasireotide in Recurrent Cushing’s Disease: Experience of Patients Treated for At Least 1 Year at a Single Center
por: Yedinak, Chris G., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_mhgnbe2uc7gv9p1f9ehgrdmscc